PAYAL AMIN: Open Payments
NPI 1982980173 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $50 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Pulmonx Corporation | 1 | $14 |
Products named: TRELEGY ELLIPTA, NUCALA, UPTRAVI, TEZSPIRE, CHARTIS CATHETER.
Industry payments across CT — which companies pay providers there.
